NO20084672L - Binder for C-reaktiv protein - Google Patents

Binder for C-reaktiv protein

Info

Publication number
NO20084672L
NO20084672L NO20084672A NO20084672A NO20084672L NO 20084672 L NO20084672 L NO 20084672L NO 20084672 A NO20084672 A NO 20084672A NO 20084672 A NO20084672 A NO 20084672A NO 20084672 L NO20084672 L NO 20084672L
Authority
NO
Norway
Prior art keywords
crp
polypeptide
reactive protein
binds
relates
Prior art date
Application number
NO20084672A
Other languages
English (en)
Inventor
Lars Baltzer
Original Assignee
Modpro Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modpro Ab filed Critical Modpro Ab
Publication of NO20084672L publication Critical patent/NO20084672L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)

Abstract

Oppfinnelsen angår en polypeptiddimer, hvori begge protomerer har en sekvens ifølge SEQ ID NO: 1, hvori minst ett fosfocholinderivat er festet til nevnte polypeptid. Nevnte polypeptid viser en spesifikk binding for C-reaktivt protein (CRP). Oppfinnelsen angår videre anvendelsen av polypeptidet i undersøkelser for å bestemme konsentrasjonen av CRP, rensing av CRP og sammensetningen omfattende CRP.
NO20084672A 2006-04-07 2008-11-07 Binder for C-reaktiv protein NO20084672L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0600794 2006-04-07
PCT/SE2007/050227 WO2007117215A1 (en) 2006-04-07 2007-04-10 Binder for c-reactive protein

Publications (1)

Publication Number Publication Date
NO20084672L true NO20084672L (no) 2008-12-10

Family

ID=38581404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084672A NO20084672L (no) 2006-04-07 2008-11-07 Binder for C-reaktiv protein

Country Status (7)

Country Link
US (2) US8017347B2 (no)
EP (1) EP2007801A4 (no)
JP (1) JP5232769B2 (no)
CN (1) CN101415727A (no)
CA (1) CA2647271A1 (no)
NO (1) NO20084672L (no)
WO (1) WO2007117215A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105063001A (zh) 2009-09-16 2015-11-18 新基阿维罗米克斯研究公司 蛋白激酶复合物和含有该复合物的药物组合物以及它们的用途
KR101118760B1 (ko) * 2009-12-29 2012-03-13 재단법인대구경북과학기술원 펜트락신 단백질 검출용 분자각인 고분자 및 그 제조방법
KR20130067487A (ko) 2009-12-30 2013-06-25 아빌라 테라퓨틱스, 인크. 단백질의 리간드-지정 공유 변형
EP2571487B1 (en) * 2010-05-21 2023-01-04 Siemens Healthcare Diagnostics Inc. Zwitterionic reagents
CN103313724A (zh) * 2010-09-06 2013-09-18 莫徳普罗有限公司 化合物和方法
EP2957563A1 (en) * 2014-06-19 2015-12-23 Pentracor GmbH Separation material comprising phosphoryl choline derivatives
EP3020726A1 (de) * 2014-11-12 2016-05-18 Pentracor GmbH Verwendung einer Citrat-Lösung zur affinitätschromatographischen Aufreinigung von CRP mittels Phosphocholin und dessen Derivaten
CN109946273A (zh) * 2019-03-13 2019-06-28 长春理工大学 一种用于检测c-反应蛋白的荧光探针及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH095325A (ja) * 1995-06-19 1997-01-10 Nissui Pharm Co Ltd 免疫凝集反応試薬および免疫分析方法
JP4242499B2 (ja) * 1999-03-03 2009-03-25 オリエンタル酵母工業株式会社 ホスホリルコリンを用いたｃｒｐの測定方法
US7390795B2 (en) 2000-12-18 2008-06-24 Pentraxin Therapeutics Limited Treatment and prevention of tissue damage
SE0202473D0 (sv) * 2001-11-21 2002-08-19 A & Science Ab Site selective acylation
SE0200968D0 (sv) * 2002-03-26 2002-03-26 Lars Baltzer Novel polypeptide scaffolds and use thereof
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
EP1597281A1 (en) 2003-02-27 2005-11-23 TheraVision GmbH Method for reducing levels of c-reactive protein

Also Published As

Publication number Publication date
CN101415727A (zh) 2009-04-22
US8436138B2 (en) 2013-05-07
US20120053124A1 (en) 2012-03-01
WO2007117215A1 (en) 2007-10-18
US8017347B2 (en) 2011-09-13
US20090305298A1 (en) 2009-12-10
EP2007801A4 (en) 2010-08-04
EP2007801A1 (en) 2008-12-31
JP5232769B2 (ja) 2013-07-10
WO2007117215A8 (en) 2009-11-05
JP2009533339A (ja) 2009-09-17
CA2647271A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
NO20084672L (no) Binder for C-reaktiv protein
ATE527353T1 (de) Pdgf-bindendes polypeptid aus protein a
NO20076056L (no) Fremgangsmater for rensing av FC region inneholdende proteiner
NO20083268L (no) Antistoffer anvist til HER-3 og anvendelser derav
ES2585185T3 (es) Polipéptidos quiméricos y sus aplicaciones terapéuticas contra una infección por Flaviviridae
NO20063026L (no) Antistoffer
ATE496304T1 (de) Ligand für den formylpeptidrezeptorähnlichen-2 (fprl2) g protein gekoppelten rezeptor
UA108066C2 (uk) Білки, що зв'язуються з cgrp-рецепторами людини
ATE471169T1 (de) Engineering mit homing-faktoren
Lewis et al. The amino acid sequence of rabbit cardiac tropomyosin.
NO20074916L (no) P-cadherin antistoff
ATE536419T1 (de) Transposon basiertes targeting- system
UA106458C2 (uk) Чутливий до сульфонілсечовини репресорний білок
RS54066B1 (en) COMPLETELY HUMAN ANTI-VAP-1 MONOCLONAL ANTIBODIES
NO20091264L (no) Anti-myostatin antistoffer
ATE455127T1 (de) Humane anti-humane cd3-bindungsmoleküle
SG159458A1 (en) Novel immunoglobulin-binding proteins with improved specificity
EA200970131A1 (ru) Миметические антитела для glp-1 человека, композиции, способы и применения
EP2730654A3 (en) Neukinase, a downstream protein of neuregulin
RU2014132108A (ru) Slit-robo сигналинг для диагностики и лечения заболевания почек
EA201400390A1 (ru) Антитела к tl1a и их применение
TW200745159A (en) IL-6 binding proteins
EP2091563A4 (en) NEUTRALIZATION OF MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NGR) AND USES THEREOF
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
NO20021686D0 (no) Fremgangsmåter for fremstilling av målemolekyler i et transgent dyr og rensing av målmolekylet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application